You are currently viewing Teddy Laboratory (GuanHe Prescribed drugs) Indicators Strategic Cooperation Settlement with LabConnect to Forge a New Panorama in Laboratory Providers Collaboration

Teddy Laboratory (GuanHe Prescribed drugs) Indicators Strategic Cooperation Settlement with LabConnect to Forge a New Panorama in Laboratory Providers Collaboration


JOHNSON CITY, Tenn., Could 30, 2025 /PRNewswire/ — Teddy Laboratory, a subsidiary of Tigermed, formally signed a strategic cooperation settlement with LabConnect, LLC, a worldwide chief in central laboratory providers. The 2 events will collectively construct a full-chain laboratory service system protecting each China and worldwide markets to speed up the event and commercialization of revolutionary medicine worldwide.

LabConnect LogoLabConnect Logo

With this settlement, Teddy Laboratory will turn out to be LabConnect’s most well-liked laboratory accomplice in China, offering lab providers that meet worldwide regulatory requirements and supporting multinational pharmaceutical corporations conducting scientific trials in China. In the meantime, LabConnect will turn out to be Teddy Lab’s most well-liked central lab accomplice for abroad operations, leveraging its intensive presence in key markets comparable to North America and Europe to assist Chinese language pharmaceutical corporations increase globally.

Teddy Laboratory and LabConnect will set up a long-term most well-liked partnership, forming a complementary mannequin of “China-based capabilities + world service community.”  “By totally leveraging our respective sources and technological strengths, we intention to additional improve world scientific trial service requirements,” mentioned Jeff Mayhew Chief Growth Officer of LabConnect.

On the signing ceremony, Ms. Xu Yi, Chairwoman of Teddy Laboratory/GuanHe Prescribed drugs, said “LabConnect’s distinctive enterprise mannequin aligns effectively with Teddy’s localized strengths. Since our first Section III scientific challenge collectively in 2022, we’ve efficiently accomplished a number of worldwide scientific trial collaborations.”

This strategic partnership marks not solely a key milestone in Teddy Laboratories world growth but additionally a deep integration of home and worldwide central lab sources. Sooner or later, each events will proceed working collectively to reinforce world scientific trial service capabilities, help the event and launch of revolutionary medicine worldwide, and convey extra superior remedy choices to sufferers.

About LabConnect

LabConnect is the main supplier of Central Laboratory Providers, FSP and Scientific Consulting, and Information Integration and Transformation Providers for analytically and logistically complicated research comparable to immuno-oncology, cell and gene therapies, and uncommon & orphan illnesses. LabConnect’s distinctive mixture of state-of-the-art expertise, world-class laboratories, quick access to main and rising markets, and intensive specialised testing experience implies that drug growth corporations can depend on one supplier for all their central laboratory service wants. Study extra at www.labconnect.com and comply with on LinkedIn.

About Teddy Laboratory/GuanHe Prescribed drugs

Shanghai GuanHe Pharmaceutical Expertise Co., Ltd., established in 2016, is a number one revolutionary and built-in lab service platform within the scientific analysis business. With branches in Shanghai, Wuxi, Hangzhou, and Hong Kong, the corporate has constructed a one-stop service functionality in central laboratory and bioanalysis, changing into an necessary participant in full-chain scientific trial providers. Teddy is a subsidiary managed by Tigermed (300347.SZ / 3347.HK).

Teddy supplies laboratory and scientific options to revolutionary drug corporations to speed up drug growth and regulatory submissions. Its providers span from biomarker discovery, goal validation, affected person enrichment, PK/PD research, security analysis, to efficacy evaluation and pattern evaluation. Teddy is dedicated to supporting scientific drug growth with cutting-edge lab applied sciences. As of March 2025, Teddy has supported the approval of 37 new medicine and therapeutic merchandise by China’s NMPA.

Brand – https://mma.prnewswire.com/media/2611513/LabConnect_Logo.jpg

Team EelaTeam Eela
WRITTEN BY

Crew Eela

TechEela, the Bedrock of MarTech and Innovation, is a Digital Media Publication Web site. We see so much round us that must be informed, shared, and skilled, and that’s precisely what we provide to you as pictures. As we wish to say, “Here is to all the pieces you ever thought you knew. To all the pieces, you by no means thought you knew”



Leave a Reply